Raymond James & Associates Standard Biotools Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$120 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$98.5 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$36.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$29.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$25.6 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $132M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...